St. Jude Medical (NYSE: STJ) reported Q1 EPS of $0.90, $0.02 better than the analyst estimate of $0.88. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

St. Jude Medical sees Q2 2016 EPS of $1.05-$1.07, versus the consensus of $1.02.

For earnings history and earnings-related data on St. Jude Medical (STJ) click here.